AACP
EHC icon

Advantage Alpha Capital Partners’s Encompass Health EHC Stock Holding History

Advantage Alpha Capital Partners’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-24,384
Closed -$3.1M – 38
2025
Q3 		$3.1M Sell
24,384
-3,474
-12% -$414K 0.93% 48
2025
Q2 		$3.42M Sell
27,858
-31,005
-53% -$3.54M 0.92% 62
2025
Q1 		$5.96M Sell
58,863
-16,477
-22% -$1.61M 1.46% 14
2024
Q4 		$6.96M Sell
75,340
-95
-0.1% -$9.33K 1.64% 10
2024
Q3 		$7.29M Sell
75,435
-14,350
-16% -$1.29M 1.66% 8
2024
Q2 		$7.7M Sell
89,785
-23,235
-21% -$1.95M 1.68% 14
2024
Q1 		$9.33M Sell
113,020
-12,517
-10% -$917K 1.76% 7
2023
Q4 		$8.38M Buy
125,537
+3,285
+3% +$213K 1.59% 11
2023
Q3 		$8.21M Sell
122,252
-28,442
-19% -$1.96M 1.72% 16
2023
Q2 		$10.2M Sell
150,694
-51,538
-25% -$3.23M 2.04% 4
2023
Q1 		$10.9M Sell
202,232
-71,811
-26% -$4.18M 2.28% 3
2022
Q4 		$16.4M Buy
274,043
+38,516
+16% +$2.09M 3.32% 2
2022
Q3 		$10.7M Buy
235,527
+42,438
+22% +$2.12M 1.96% 17
2022
Q2 		$8.61M Buy
193,089
+44,181
+30% +$2.27M 1.49% 24
2022
Q1 		$8.42M Sell
148,908
-33,294
-18% -$1.74M 1.26% 26
2021
Q4 		$9.46M Buy
182,202
+56,760
+45% +$2.93M 1.35% 24
2021
Q3 		$7.49M Buy
125,442
+21,359
+21% +$1.34M 1.37% 24
2021
Q2 		$6.46M Buy
104,083
+4,050
+4% +$270K 1.25% 25
2021
Q1 		$6.52M Sell
100,033
-5,278
-5% -$344K 1.37% 20
2020
Q4 		$6.93M Sell
105,311
-96,103
-48% -$5.65M 1.52% 19
2020
Q3 		$10.4M Buy
201,414
+34,869
+21% +$1.79M 2.41% 1
2020
Q2 		$8.21M Buy
166,545
+78,549
+89% +$4.24M 1.92% 6
2020
Q1 		$4.48M Sell
87,996
-38,612
-30% -$2.23M 1.6% 17
2019
Q4 		$6.98M Buy
+126,608
New +$6.87M 1.88% 7

Other funds holding EHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Advantage Alpha Capital Partners's EHC Position: Q4 2025 in Review

Advantage Alpha Capital Partners sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 24,384 shares — an estimated $3.1M sold.

Advantage Alpha Capital Partners first reported a position in EHC in Q4 2019 and held it in 24 quarters. The position peaked at $16.4M in Q4 2022. 593 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

  • Advantage Alpha Capital Partners reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 24,384 Encompass Health shares in Q4 2025, an estimated $3.1M.
  • Advantage Alpha Capital Partners first reported a position in Encompass Health in Q4 2019 and held it in 24 quarters.
  • Advantage Alpha Capital Partners's Encompass Health position peaked at $16.4M in Q4 2022.
  • 593 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Advantage Alpha Capital Partners's 13F filing for Q4 2025.